J Biol Chem, Vol. 275, Issue 5, 3192-3200, February 4, 2000
Regulation of Pap Phase Variation
Lrp IS SUFFICIENT FOR THE ESTABLISHMENT OF THE PHASE OFF
pap DNA METHYLATION PATTERN AND REPRESSION OF pap
TRANSCRIPTION IN VITRO*
Nathan J.
Weyand and
David A.
Low
From the Department of Molecular, Cellular, and Developmental
Biology, University of California,
Santa Barbara, California 93106
 |
ABSTRACT |
The pyelonephritis-associated pili
(pap) operon in Escherichia coli is regulated
by an epigenetic mechanism involving the formation of specific DNA
methylation patterns characteristic of transcriptionally active (phase
ON) and inactive (phase OFF) cells. The formation of pap
DNA methylation patterns in vivo was previously shown to
require the leucine-responsive regulatory protein (Lrp) and DNA adenine
methylase (Dam). To monitor the binding of Lrp to pap DNA,
an in vitro methylation protection assay was developed.
Binding of Lrp to a Dam target site proximal to the papBA
promoter (designated GATCprox) blocked methylation of this
site and specifically repressed transcription. The DNA methylation
pattern and transcription state are identical to those observed
in vivo in phase OFF cells. To determine if binding of Lrp
at GATCprox was necessary for repression of
papBA transcription, we analyzed a pap mutation
(pap-13) that reduced the affinity of Lrp for the GATCprox region. Binding of Lrp to pap-13 DNA
was shifted to a promoter distal Dam target site (designated
GATCdist). Lrp blocked methylation of GATCdist
in the pap-13 mutant, but did not repress papBA
transcription. Together, these results show that binding of Lrp to the
GATCprox region is sufficient for the establishment of the
phase OFF DNA methylation pattern and repression of papBA transcription.
 |
INTRODUCTION |
The pyelonephritis-associated pili
(pap)1 operon
codes for pili, which mediate adhesion of uropathogenic
Escherichia coli to host uroepithelial cells (1). The
expression of Pap pili is regulated by phase variation, a process by
which individual cells switch between expression (phase ON) and
non-expression (phase OFF) states (2). Pap phase variation is
controlled at the transcriptional level by a complex epigenetic
mechanism involving the formation of specific DNA methylation patterns,
similar to that observed in certain eukaryotic systems (3). DNA
methylation has been shown to control the binding of the global
regulator leucine-responsive regulatory protein (Lrp) (4, 5) to
pap regulatory DNA sequences (6-9). In addition, the
pap-encoded co-regulator PapI has also been shown to control
the binding of Lrp to pap regulatory DNA (8, 10, 11).
Genetic analyses showed that Lrp, PapI, and DNA adenine methylase (Dam)
were all necessary for pap transcription (6).
Lrp binds cooperatively to two pap DNA regions in
vitro, each containing a GATC sequence, which is the target of Dam
(Fig. 1). In vivo DNA analysis showed that, in phase OFF
cells, the GATC site proximal to the papBA promoter
(GATCprox) was protected from methylation, whereas the GATC
site distal to the promoter (GATCdist) was fully
methylated. Conversely, in phase ON cells, the GATCprox
site was fully methylated and GATCdist was protected from
methylation (6). In the absence of Lrp, GATCprox and
GATCdist were not protected from methylation, showing that
Lrp was essential for the phase ON and phase OFF DNA methylation
patterns observed in vivo (12). Based on these data, it was
speculated that, in phase OFF cells, Lrp was bound near
GATCprox whereas in phase ON cells Lrp was bound near
GATCdist (13).
DNA footprint analysis was consistent with this interpretation of the
DNA methylation pattern data. Lrp bound cooperatively and with highest
affinity to pap Lrp DNA binding sites 1, 2, and 3 encompassing GATCprox in vitro. Addition of PapI
shifted the binding of Lrp to pap DNA Lrp binding sites 4, 5, and 6 over 100 base pairs upstream (relative to the papBA
promoter) encompassing GATCdist (8) (see Fig. 1). Moreover,
binding of Lrp-PapI to pap Lrp binding sites 4, 5, and 6 was
blocked when GATCdist was fully methylated, providing a
means by which DNA methylation could control the Pap phase variation
switch (10).
Although Lrp was shown to bind to pap regulatory DNA
encompassing the GATCdist and GATCprox sites
in vitro, it was not clear if this was sufficient for the formation of the DNA methylation patterns observed for phase ON and
phase OFF cells in vivo, or how this binding affected
pap transcription (14). Here we show that the phase ON and
phase OFF pap DNA methylation patterns can be established
in vitro by Lrp alone. Moreover, binding of Lrp to
GATCprox was sufficient for repression of papBA
transcription. These studies provide an in vitro system for
the biochemical analysis of Pap phase variation.
 |
EXPERIMENTAL PROCEDURES |
Chemicals and Reagents--
Restriction endonucleases and T4
polynucleotide kinase were purchased from New England Biolabs.
AMV-reverse transcriptase, RNasin ribonuclease inhibitor, and
ribonuclease (RNase ONETM) were purchased from Promega.
E. coli RNA polymerase (
70) holoenzyme was
from Epicentre Technologies. Nucleotides were obtained from NEN Life
Science Products. Oligonucleotides used for this study were purchased
from the Protein-DNA Core Facility (Cancer Center, University of Utah,
Salt Lake City, UT) or Genosys Biotechnologies, Inc.
Purification of Proteins--
Lrp was purified (Margareta
Krabbe)2 from strain JWD3-1
(a gift from Rowena Matthews). Lrp protein concentrations were
estimated by absorbance at 280 nm, assuming a molar extinction
coefficient of 1197 for tyrosine (15) and five tyrosines per monomer of Lrp. Preparations of Lrp were judged to be equal to or greater than
95% pure by SDS-polyacrylamide gel electrophoresis (PAGE) and
Coomassie Blue staining.2
Dam was overexpressed using plasmid pDOX1 containing E. coli
dam under control of the phage
PL promoter (16).
E. coli DL3322 containing pDOX1 was grown in Luria-Bertani
broth to an A600 of 0.6 at 37 °C, shifted to
a 42 °C shaking water bath for 1 h, and then transferred back
to 37 °C for an additional 2 h. Bacterial cells were
centrifuged (3,000 × g, 10 min), and the cell pellet
was resuspended in 30 ml of buffer A (50 mM sodium phosphate, 10 mM EGTA, 10% (v/v) glycerol, 10 mM
-mercaptoethanol, 1 mM
phenylmethylsulfonyl fluoride) containing 1 M NaCl. The
cell suspension was broken using a French pressure cell, and cell
debris was removed by centrifugation at 20,000 × g for
20 min. Polyethylenimine was added to the supernatant (0.1% v/v),
incubated 15 min at room temperature, and centrifuged at 48,000 × g for 20 min. Ammonium sulfate was added to the supernatant
(44.2 g/100 ml), stirred at 4 °C for 30 min, and centrifuged at
27,000 × g for 15 min. Cell pellets were resuspended
in 16 ml of buffer A and dialyzed against buffer A. Dialyzed cell
extract was applied to a 20-ml phosphocellulose P-11 column (Whatman)
previously equilibrated with buffer A. A linear gradient (0-1
M NaCl) was applied, and Dam-containing fractions were
pooled and dialyzed against 50 mM Tris-HCl, pH 7.5, 50 mM KCl, 10 mM EDTA. Bovine serum albumin (BSA,
200 µg ml
1 final w/v) and glycerol (50% final v/v)
were added for storage at
20 °C. Dam protein was found to be 70%
pure by SDS-PAGE and Coomassie staining. Dam protein concentrations
were estimated by absorbance at 280 nm, based on molar extinction
coefficients of 0.7 for phenylalanine, 5559 for tryptophan, and 1197 for tyrosine (15).
Strains, Media, and Plasmids--
The E. coli strains
and plasmids used in this study are shown in Table I. Isogenic E. coli strains (Table I) containing dam-16,
rpoD800, and katF13::Tn10
were constructed by P1 transduction (17). Cultures used for RNA
isolation and subsequent primer extension analyses were grown at the
indicated temperatures under aeration in minimal medium M9 (17)
supplemented with 0.2% (v/v) glycerol as the sole carbon source.
Antibiotics were added to the following final concentrations:
kanamycin, 25 µg ml
1; tetracycline, 12.5 µg
ml
1. The chromogenic substrate
5-bromo-4-chloro-3-indolyl-D-galactoside (X-gal; Alexis
Corp.) was added to a final concentration of 40 µg ml
1
in M9 agar medium as needed. The site-directed mutagenesis protocol of
Kunkel (18) was used to introduce a substitution mutation into Lrp
binding site 3 of pDAL337 (6) as described previously (8) to create
pDAL337-13. Plasmids pDAL337 and pDAL337-13 were transformed into
DL3338 (dam-16) to produce nonmethylated plasmid DNAs.
Strains harboring plasmids were grown in Luria-Bertani broth (17)
containing ampicillin (100 µg ml
1) to an
A600 greater than 2. Large scale preparations of
plasmid DNA of native superhelical densities were isolated by alkaline lysis and two rounds of CsCl gradient centrifugation essentially as
described (19). Ethidium bromide was extracted from the DNA using
H2O/NaCl-saturated isopropanol. Plasmid DNA was
precipitated with ammonium acetate and ethanol followed by resuspension
in Tris-EDTA buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) and dialysis against the same buffer. Plasmid DNA
concentrations were determined by optical density
(A260) and confirmed by gel electrophoresis. Plasmids were 100% non-methylated at GATC sites as determined by
comparison of Sau3AI and MboI restriction
digests. The supercoiling states of each plasmid preparation were
assessed by two dimensional gel electrophoresis on 0.5% (w/v) agarose
in the presence of chloroquine diphosphate as described previously
(20). The DNA was transferred to Hybond-N membranes (Amersham Pharmacia
Biotech) in 3 M NaCl, 0.3 M sodium citrate,
using a PosiBlot pressure blotter (Stratagene), and fixed to membranes
by UV cross-linking. Blots were probed with 32P-labeled RNA
synthesized from 1 µg of pTZ19U plasmid template using the Maxiscript
T7 RNA polymerase in vitro transcription kit (no. 1312;
Ambion). Hybridization was performed in ULTRAhyb (Ambion) at 42 °C,
followed by washing as directed by the manufacturer. Autoradiography
showed that each plasmid preparation contained overlapping
distributions of topoisomers; the exact linking numbers were not
determined. The monomeric populations of plasmid pDAL337 and pDAL337-13
were estimated to be 85% and 90% supercoiled, respectively. We
estimate that approximately 70% of each plasmid preparation was
supercoiled monomer.
Calculation of pap Phase Variation Switch Rates and the Fraction
of Phase ON Cells--
The pap phase ON to OFF and OFF to
ON switch frequencies (number of switch events per cell per generation)
and the fraction of bacteria in the phase ON state were determined as
described previously (21).
RNA Isolation and Primer Extension Analysis--
The
oligonucleotides used for primer extension were:
5'-AGGGAATAAGGGCGACACGGAAATGTTGAATAC-3' for
-lactamase and
5'-ATAGTCCTGGCCTGAATCGACAGCGTTATTTTG-3' for csiD. A
DNA sequence ladder was constructed for positioning of transcription
start sites using plasmid pDAL337 DNA template and the oligonucleotide
primers shown above. DNA cycle sequencing was performed as directed
(Life Technologies, Inc.).
For RNA isolation, E. coli strains were initially grown on
M9 glycerol X-gal plates with the appropriate antibiotic(s) (Table I). Strains DL3319 and DL3321 were grown
at 30 °C to an A600 of 0.5 and then divided
into two aliquots grown at 30 °C and 42 °C for another 1 h
prior to RNA isolation. E. coli strains DL1504, DL2121, and
DL3033 were grown at 37 °C prior to RNA isolation. To ensure that a
high percentage of phase ON cells were present, bacteria were streaked
on M9 glycerol medium containing X-gal indicator and blue
(Lac+) colonies were selected. This process was repeated,
and blue colonies were used to inoculate M9 glycerol cultures for RNA
isolation (15 ml).
RNA was isolated as follows; 10 ml of each culture was added to 2 ml of
lysis buffer (250 mM Tris-HCl, pH 6.8, 10 mM
EDTA, 10% SDS) in a 50-ml conical tube and boiled for 2 min. After a 3-min incubation at room temperature, 0.5 ml of 2 M sodium
acetate·3H2O, pH 5.2, plus 10 ml of phenol
(buffered with 50 mM Tris-HCl, pH 7.9) were added. After
vigorous shaking for 5 min, 10 ml of chloroform was added and mixed for
another 5 min. The samples were then centrifuged at ~1400 × g for 10 min. The aqueous layer was transferred to a fresh
tube and the phenol and chloroform extractions repeated as above until
the interface was clearly demarcated (typically 3-4 extractions). The
aqueous layer of each tube was split into two 30-ml Corex tubes,
followed by addition (to each) of 0.75 ml of glacial acetic acid and
ammonium acetate to a final concentration of 0.2 M. RNA was
precipitated by addition of two sample volumes of ethanol and incubated
at
20 °C for at least 2 h. Samples were centrifuged at
10,500 × g for 30 min. Pellets were air-dried and
suspended in 270 µl of diethyl pyrocarbonate-treated H2O.
DNase buffer (30 µl of 40 mM Tris-HCl, pH 7.9, 10 mM NaCl, 6 mM MgCl2) was added
along with 5 units of RNase-free DNase I (Stratagene). Samples were
incubated at 37 °C for 1 h followed by phenol/chloroform (1:1)
extraction. RNAs were precipitated with 1/10 volume 10 M
ammonium acetate plus two volumes of ethanol (100%). RNAs were
pelleted by centrifugation, air-dried, resuspended in diethyl
pyrocarbonate double-distilled H2O, and stored at
70 °C. RNA concentration was determined based on the absorbance at 260 nm.
For each primer extension reaction, 50 µg of RNA was added to 50,000 cpm of end-labeled primer, and precipitated with ethanol. Air dried
pellets were resuspended in 30 µl of hybridization buffer (3 M NaCl, 0.5 M HEPES, 1 mM EDTA, pH
7.8). After overnight incubation at 30 °C, the hybridized RNA and
primers were precipitated by addition of 170 µl of 0.3 M
sodium acetate (pH 5.2) and 500 µl of 100% ethanol. The RNA-primer
hybrids were pelleted by centrifugation, air-dried, and resuspended in
25 µl of reverse transcription buffer (50 mM Tris-HCl, pH
8, 50 mM KCl, 5 mM
MgCl2·6H2O, 5 mM dithiothreitol, 50 µg/ml BSA, 55 mM dNTPs, and 0.8 units/µl RNasin).
AMV-reverse transcriptase (40 units) was added to each reaction
followed by incubation at 42 °C for 90 min. Reverse transcription
reactions were terminated by addition of 1 µl of 0.5 M
EDTA and 1 µl of Rnase ONETM, followed by a 30-min
incubation at 37 °C. Ammonium acetate (100 µl of 2.5 M) was added to each sample followed by extraction with 125 µl of phenol/chloroform (1:1). RNA (aqueous phase) was precipitated in ethanol, cDNAs were resuspended in 3.75 µl of Tris-EDTA
buffer, pH 7.4, and 5 µl of primer extension loading buffer (98%
formamide (v/v), 1 mg/ml xylene cyanol, 1 mg/ml bromphenol blue, 10 mM EDTA) was added. Samples were separated on
polyacrylamide gels (6%) in 1× TBE buffer (89 mM Tris
base, 89 mM boric acid, 1 mM EDTA) containing 8 M urea.
In Vitro Transcription Reactions--
In vitro
transcription was performed using supercoiled plasmid DNA (2 nM) pre-incubated for 15 min at 37 °C with varying
concentrations of purified Lrp. Reactions were performed in 100 mM KCl, 40 mM Tris-HCl, pH 8, 5 mM
MgCl2, 0.1 mM EDTA, 0.1 mg/ml BSA, 2 mM dithiothreitol, 1 mM
-mercaptoethanol,
6% glycerol, 80 µM S-adenosyl methionine, 500 µM NTP (125 µM each of ATP, UTP, CTP, and
GTP), 0.8 units/µl RNasin. In addition, a radiolabeled, gel-purified
murF DNA fragment (12,500 cpm/reaction) was included as a
control for recovery of nucleic acids and subsequent quantitation of
transcript levels. The 109-bp murF DNA fragment was
prepared by PCR using 32P-end-labeled oligonucleotide
5'-CGGAATTCATGATTAGCGTAACCCTTA-3' and non-labeled oligonucleotide
5'-CTGGATCCTAATACGACTCACTATAGGGAGGGGGTGATATCTGCACCTT-3' with chromosomal DNA template from E. coli strain
MC4100. The murF DNA fragment was gel-purified prior to use.
Transcription was initiated by the addition of RNA polymerase (25 nM), and at the same time Dam methylase (100 to 200 nM) was added (titrated previously to completely methylate
both pap GATC sites in 5 min). Transcription reactions were
terminated after 5 min at 37 °C by addition of 50 µl of stop
solution (50 mM Tris-HCl, pH 7.4, 50 mM EDTA,
pH 8) followed by heating at 65 °C for 20 min. After the addition of
10 µg of yeast RNA, each reaction was extracted with
phenol/chloroform/isoamyl alcohol (25:24:1). A portion of each sample
was precipitated with ammonium acetate and ethanol and used as template
for primer extension of in vitro synthesized RNAs.
In vitro synthesized RNA transcripts were analyzed by primer
extension as follows. RNA transcripts were suspended in reverse transcription buffer with 50,000 cpm each of end-labeled pap
or bla primer (see above). AMV-reverse transcriptase was
added to each reaction followed by a 90-min incubation at 42 °C.
Reactions were terminated by the addition of 1 µl of 0.5 M EDTA, pH 8.0, and 10 units of RNase ONETM
followed by incubation at 37 °C for 30 min. Ammonium acetate (100 µl of 2.5 M) was added to each sample, and samples were
then extracted with phenol/chloroform (1:1). The cDNAs were
precipitated with ethanol.
Analysis of primer extension products was carried out by polyacrylamide
gel electrophoresis as described above. Transcripts were quantitated
using an Alpha Imager 2000 documentation and analysis system (Alpha
Innotech Corp., San Leandro, CA). The pap and bla
transcript values from each lane were divided by the murF loading control value and plotted relative to two 0 nM Lrp
controls (RNA polymerase only).
In Vitro Methylation Protection Assays--
The in
vitro methylation protection assay was performed as described for
in vitro transcription reactions (see above), with the
following modifications. RNA polymerase, radiolabeled murF probe, and RNasin were not added, and reactions were stopped with phenol/chloroform (1:1). Reactions were desalted by gel chromatography (P-30 spin column, Bio-Rad) and digested with EcoRI and
MboI. Digested DNA was separated on 3.5% polyacrylamide
gels run (1× TBE buffer). Gels were blotted by electrotransfer
(ZetaProbe membranes, Bio-Rad) according to standard protocol (19). A
PCR-generated DNA template incorporating a bacteriophage T7 promoter
sequence was amplified using plasmid pDAL337 DNA template with the
following oligonucleotides:
5'-AATTTAATACGACTCACTATAGGGATCAATTTGCCATGATGTTTTTA-3' (the
italicized portion represents the T7 RNA polymerase promoter) and
5'-GATCTTTTAACCCACAAAACA-3'. An RNA probe was synthesized using the PCR
product as template for T7 RNA polymerase (Maxiscript, Ambion).
Briefly, 1 µg of PCR-generated template DNA was combined in
transcription buffer (20 µl total volume) with the four nucleotide triphosphates, RNasin (10 units), and T7 RNA polymerase (10 units). The
reaction mix was incubated at 37 °C for 4 h, and DNA template was removed by incubation with DNase I at 37 °C for 15 min.
Unincorporated nucleotides were removed by gel chromatography (P-30
spin column, Bio-Rad). Blots were hybridized using an RNA probe (87 nucleotides) hybridizing to pap DNA sequences between
GATCdist and GATCprox (Fig. 4A).
Blots were probed in ULTRAhyb (Ambion) at 42 °C with 106
cpm ml
1 of the RNA probe, followed by washes as directed
by the manufacturer. Restriction fragments were visualized by
autoradiography and quantified (see above).
 |
RESULTS |
Transcription at the papBA Promoter Is Dependent upon the RNA
Polymerase Sigma Factor
70--
The primary sigma
factor used for transcription in E. coli during logarithmic
growth is
70 (22). Since the pap operon is
transcribed in E. coli cells growing logarithmically (6), it
seemed likely that the RNA polymerase-
70 holoenzyme
transcribes the pap operon. To test this hypothesis, a
mutation in the rpoD gene (rpoD800) encoding
70 was transduced into E. coli containing a
papBA-lacZ operon fusion. At the permissive temperature
(30 °C) the rpoD800 allele does not significantly alter
the transcription of
70-dependent promoters
whereas at the nonpermissive temperature (42 °C) transcription is
totally blocked (23, 24). Analysis of the effect of rpoD800
on pap gene expression showed that even at the permissive
temperature pap transcription was blocked as evidenced by
the absence of bacterial cells in the phase ON transcription state
(Table II). These results show that
70 is required for pap transcription.
Transcription at many promoters is initiated by both the
70 and
38 sigma factors, which share
overlapping DNA binding specificities (25). Additionally, because a
number of virulence genes are dependent on
38 for
transcription (26-28), we determined if
38 played a
role in activation of pap transcription. As shown in Table
II, introduction of a null mutation in rpoS encoding
38 (katF13::Tn10) did
not significantly alter pap transcription, as evidenced by
measurement of pap phase variation switch frequencies. Together, these data indicate that
70 is the principal
sigma factor used for pap transcription.
Further analysis of the roles of
70 and
38 in pap transcription was carried out by
primer extension analysis. For these studies, a pap mutant
(pap-13, Fig. 1) containing a
substitution mutation in Lrp binding site 3 was used since it confers a
constitutive pap transcription phenotype (8). First, wild
type pap and pap-13 transcription were analyzed
at the permissive and restrictive temperatures in strains containing
rpoD800. In log phase, rpoD800 prevented wild
type papBA transcription at both the permissive (30 °C)
and non-permissive (42 °C) temperatures (Fig.
2A). In contrast, mutant
pap-13 was transcribed at 30 °C but not at 42 °C.
These results indicate that
70 is the primary sigma
factor responsible for pap transcription in log phase cells.
When pap-13 RNA was isolated from stationary phase cells of
strains with a transposon insertion in rpoS, papBA transcription was not reduced (Fig. 2B) whereas
transcription from csiD, a known
38-dependent promoter (29), was abolished.
Similar results were obtained using a wild type papBA
promoter.3 These studies
support the hypothesis that
70 is the primary
sigma factor responsible for papBA transcription.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
The papBA promoter
regulatory region. A, Lrp binding sites are numbered
1 to 6 with the distance (base pairs) relative to
the papBA transcription start site shown. The
GATCdist and GATCprox DNA sequences are located
within Lrp binding sites 5 and 2, respectively. The methylated adenines
of the GATCdist and GATCprox sites are located
at 154 and 52 relative to the papBA transcription start
site, respectively. The DNA methylation patterns of phase ON and phase
OFF E. coli are shown (nonmethylated GATC (open
circle), methylated GATC (filled
circle)). B, the nucleotide sequence of the
papBA promoter region from 62 to +5 is shown. The promoter
consensus for E. coli 70 holoenzyme is also
shown (38, 39). The 35 and 10 hexamers of papBA are
underlined. The pap-13 mutation is in
italics. Lrp binding sites 2 and 3 are
boxed.
|
|

View larger version (86K):
[in this window]
[in a new window]
|
Fig. 2.
Primer extension analysis of in
vivo papBA transcripts. Cultures were grown
in M9 minimal medium (0.2% v/v glycerol). Radiolabeled oligonucleotide
primers complementary to papBA (panels
A and B) or csiD (panel
B) were hybridized with RNA and used as templates for
reverse transcription. Reaction products were analyzed by
polyacrylamide gel electrophoresis as described under "Experimental
Procedures." A, lanes 1 and
2, DL3319; lanes 3 and 4,
DL1504; lanes 5 and 6, DL3321. The
pap and rpoD ( 70) genotypes,
growth temperature, and percentage of phase ON cells (see
"Experimental Procedures") are shown at the bottom
(NA, not applicable). The papBA transcripts are
indicated with an arrow. The pap DNA sequence
ladder (CATG) was generated with the same oligonucleotide used for
primer extension of papBA transcripts. B,
lane 1, DL2121; lane 2,
DL3033 (katF13::Tn10). Both bacterial
cultures were 100% phase ON.
|
|
Lrp Specifically Represses papBA Transcription--
Evidence
obtained previously indicated that Lrp acts as both an activator and a
repressor of pap transcription in vivo (13). To
determine if Lrp can directly repress papBA transcription, an in vitro transcription system was developed using RNA
polymerase-
70 holoenzyme (E
70).
Transcription from both the papBA and bla
(
-lactamase) promoters was simultaneously monitored in the presence
or absence of Lrp in vitro using a primer extension assay
(see "Experimental Procedures"). The level of papBA
transcription was reduced at 8 nM Lrp and abolished at 16 nM Lrp, whereas bla transcription was not
reduced until addition of 128 or 256 nM Lrp and abolished
at 512 nM Lrp (Fig. 3). These
results showed that Lrp was sufficient for specific repression of
papBA transcription.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 3.
Lrp specifically represses papBA
transcription. A, in vitro
transcription was performed at 37 °C with plasmid template pDAL337,
and cDNA products were separated by polyacrylamide gel
electrophoresis as described under "Experimental Procedures." Equal
counts of a radiolabeled PCR product were added to each transcription
reaction to serve as a recovery control (RC). The Lrp
concentration (nM) is shown at the bottom. Lrp was added 15 min prior to addition of RNA polymerase. A control reaction lacking RNA
polymerase is shown in lane 1. B,
quantitation of pap ( , solid line)
and bla ( , dotted line) transcripts
relative to the 0 nM Lrp controls (A,
lanes 2 and 13) were performed as
described under "Experimental Procedures."
|
|
Lrp-dependent Methylation Protection at the
GATCprox Site Correlates with Repression of papBA
Transcription--
Lrp blocks methylation of the GATCprox
site in phase OFF cells and blocks methylation of GATCdist
in phase ON cells (6). Van der Woude et al. (14) showed recently that Lrp specifically blocks methylation of the pap
GATCdist and GATCprox sites in
vitro. Therefore, we developed an in vitro methylation protection assay to monitor Lrp occupancy at the pap GATC
sites. Lrp was incubated with nonmethylated pap DNA followed
by addition of Dam (see "Experimental Procedures"). The methylation
state of each GATC site was assessed by digestion with MboI,
which cuts only nonmethylated GATC sites. Sufficient Dam was added to
methylate both the GATCdist and GATCprox sites
as evidenced by the presence of the 1,784-bp pap DNA
fragment (see DNA fragment R, Fig.
4A). Lrp preferentially
protected methylation of GATCprox as evidenced by the
presence of the 1,142-bp DNA fragment (see DNA fragment S,
Fig. 4, A and B). Maximal methylation protection of GATCprox occurred at 16 nM Lrp, which was
the same concentration observed to cause maximal repression of
pap transcription (compare Figs. 3B and
4C). In contrast, methylation protection of
GATCdist was not observed until 256 nM Lrp
(Fig. 4C). At higher concentrations of Lrp, both GATC sites
were protected from methylation as evidenced by the presence of 744-, 1,142-, and 102-bp pap DNA fragments (Fig. 4A,
512 nM Lrp). These data showed that Lrp blocked methylation of the GATCprox site at the same levels required for
specific repression of papBA transcription. In contrast,
methylation protection of GATCdist did not correlate with
repression of papBA transcription.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 4.
Binding of Lrp to the pap
GATCprox site correlates with repression of
papBA transcription. A, DNA fragments
that result from MboI restriction digestion of
pap regulatory DNA when GATCdist and/or
GATCprox are protected from Dam methylation by Lrp. DNA
fragments are identified by letter and sizes (base pairs)
are shown. B, in vitro methylation protection
assays were performed as described in "Experimental Procedures"
using wild-type pap DNA (plasmid pDAL337) and the
87-nucleotide RNA probe shown in A. DNA fragment R is fully
methylated pap DNA that was not digested by MboI;
DNA fragments S and V represent digestion at a nonmethylated
GATCprox or GATCdist site, respectively. DNA
fragment Z represents cutting at both sites. DNA fragments T, X, and Y
were detected by the RNA probe, likely as a result of extension of RNA
outside of the 85-nucleotide probe region due to contaminating PCR
products. C, quantitation of DNA fragment S, V, and Z from
B. DNA fragment S ( , nonmethylated GATCprox),
V ( , nonmethylated GATCdist) and Z (*, nonmethylated
GATCdist and GATCprox).
|
|
Binding of Lrp at the GATCprox Site Is Required for
Repression of papBA Transcription--
The data shown in Fig. 4
indicated that binding of Lrp to GATCprox inhibited
pap transcription. To determine if binding of Lrp to GATCprox is required for repression of pap
transcription, the pap-13 mutant containing a mutation in
Lrp binding 3 was analyzed (Fig. 1B). This mutation reduces
the affinity of Lrp for the GATCprox region (2-3-fold) and
increases its affinity for GATCdist (4-fold) (8).
Repression of transcription from wild-type pap DNA template
occurred at 8 nM (Fig. 3A), whereas repression
of the pap-13 template was observed only at Lrp levels
higher than 256 nM (Fig.
5A). At these high levels of
Lrp, repression of the bla gene, which is not Lrp regulated,
was also observed (Fig. 5A). Thus, repression of
pap-13 transcription at the higher levels of Lrp appeared to
be due to nonspecific binding of Lrp.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 5.
Lrp does not specifically repress
transcription from the phase locked ON pap-13 mutant
DNA template. A, in vitro transcription was
performed at 37 °C with plasmid template pDAL337-13 (Table I), and
cDNA products were separated by polyacrylamide gel electrophoresis
as described under "Experimental Procedures." Equal counts of a
radiolabeled PCR product were added to each transcription reaction to
serve as a recovery control (RC). The Lrp concentration
(nM) is shown at the bottom. Lrp was added 15 min prior to addition of RNA polymerase. A control reaction lacking RNA
polymerase is shown in lane 1. B,
quantitation of pap ( , solid line)
and bla ( , dotted line) transcripts
relative to the 0 nM Lrp controls " (A,
lanes 2 and 13).
|
|
Methylation protection analysis indicated that Lrp bound to the
GATCdist site with highest affinity (Kd = 4-8 nM, Fig.
6B) in contrast to binding of
Lrp to GATCdist of wild type pap (estimated
Kd = 256-512 nM, Fig. 4C). Maximal binding of Lrp to GATCdist of pap-13
occurred at 16 nM Lrp, at which level no repression of
pap-13 transcription was observed (Fig. 5). In contrast,
binding of Lrp to GATCprox of pap-13 DNA
occurred at concentrations greater than 256 nM Lrp (Fig. 6,
A and B). At these high Lrp levels, nonspecific
repression of pap-13 transcription was observed (Fig. 5).
Thus, Lrp did not specifically repress pap-13 transcription
due to its reduced affinity for GATCprox. Together, these
results strongly indicate that binding of Lrp at GATCprox,
but not GATCdist, represses pap
transcription.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 6.
Lrp binds with highest affinity to the
GATCdist site of phase locked ON pap-13
DNA. A, in vitro methylation
protection assays were performed at 37 °C with plasmid template
pDAL337-13. Refer to Fig. 4A for identification of
pap DNA fragments. B, quantitation of DNA
fragments V, S, and Z from A. DNA fragment V ( ,
nonmethylated GATCdist), DNA fragment S ( , nonmethylated
GATCprox), and DNA fragment Z (*, nonmethylated
GATCdist and GATCprox).
|
|
 |
DISCUSSION |
In this study, we have demonstrated for the first time that Lrp
alone can establish the phase OFF and phase ON pap DNA
methylation patterns in vitro. Formation of the phase OFF
DNA methylation pattern by Lrp binding at GATCprox was
shown to result in repression of papBA transcription
in vitro. In contrast, no repression was observed when Lrp
established the phase ON methylation pattern by binding to
GATCdist in vitro (Figs. 5 and 6). The same
relationships between DNA methylation patterns and transcription
phenotypes were observed previously in vivo (6). In phase
OFF cells GATCprox was protected from methylation, whereas
in phase-locked ON cells containing pap-13,
GATCdist was protected from methylation.
In vivo in phase ON cells PapI and Lrp are required for
protection of GATCdist from Dam methylation and activation
of papBA transcription (8). Previously, PapI was shown to
increase the affinity of Lrp for the GATCdist region of
pap (8). However, in the pap-13 mutant containing a 6-bp substitution mutation in Lrp binding site 3 (Fig.
1B), PapI is no longer required for methylation protection
of GATCdist or for papBA transcription in
vivo (8). Our in vitro analysis showed that the
pap-13 mutation reversed the binding affinities of Lrp for
the two pap GATC sites, enabling Lrp binding at
GATCdist in the absence of PapI. In wild-type
pap, Lrp bound with highest affinity to
GATCprox, whereas in pap-13 Lrp bound with
highest affinity to GATCdist (compare Figs. 4C
and 6B). In vitro transcription analysis
indicated that binding of Lrp to GATCprox but not
GATCdist correlated with repression of papBA
transcription (Figs. 3 and 4). Analysis of the pap-13 mutant
showed that Lrp could not specifically repress papBA
transcription (Fig. 6). By disrupting the binding of Lrp to the
GATCprox region with the pap-13 mutation, a
direct link between binding of Lrp at GATCprox and
repression of pap transcription was established (Fig.
5).
The pap GATCprox site also plays a critical role
in activation of pap transcription. Previous results showed
that mutation of the GATCprox site to GCTC sequence blocked
pap transcription (6). The GCTCprox mutation,
however, did not significantly reduce Lrp's affinity compared with
nonmethylated wild-type pap DNA. Thus, the effects of the
GCTCprox mutation were attributed to the inability of GCTC
sequence to be methylated by Dam. In support of this hypothesis,
transcription in both wild type and the phase-locked ON
GCTCdist mutant was blocked in dam
cells (6). These data strongly indicated that methylation of
GATCprox was essential for pap transcription.
The mechanism by which methylation of GATCprox activates
papBA transcription is not clear. In phase ON cells the
GATCprox site is fully methylated (Fig. 1). Since our
results here showed that Lrp blocks GATCprox methylation
in vitro (Fig. 4), it seems likely that Lrp is not bound at
this site in phase ON cells. Based on our model for Pap phase
variation, Lrp moves from promoter proximal papBA DNA sites to promoter distal sites during the transition to the phase ON transcription state (9). Methylation of GATCprox could
assist in this transition by reducing the affinity of Lrp for
pap DNA sites proximal to the promoter, similar to the
reduction in affinity of Lrp-PapI for promoter distal sites that
results from methylation of GATCdist (10). Alternatively,
methylation of GATCprox could increase the affinity of RNA
polymerase-
70 for the papBA promoter,
facilitating transition to the phase ON state or alter the binding of
an additional regulatory factor(s).
The mutant allele of
70 (rpoD800) blocked
transcription at the wild type papBA promoter at the
permissive temperature (30 °C) as well as the non-permissive
temperature (42 °C) (Fig. 2). This is unusual since
rpoD800 had little to no effect on transcription of other
genes at the permissive temperature (23). RpoD800 contains a 14-amino
acid in frame deletion of residues 330-343 of
70, which
causes it to become unstable at temperatures above 37 °C (30).
Although the levels of RpoD800 appear to be comparable to wild type
RpoD at the permissive temperature, RpoD800 appears to have a lower
affinity for core RNA polymerase at the permissive temperature, which
could result in a lower level of RNA polymerase-
70
holoenzyme (31). Transcription of papBA may be more
sensitive to a lowered RNA polymerase level than other genes since it
may compete with Lrp for binding near GATCprox. Based on
this hypothesis, disruption of binding of Lrp to GATCprox
should restore papBA transcription at the permissive
temperature in cells containing RpoD800. Analysis of pap-13
indicated that, unlike wild type pap, transcription occurred
at the permissive temperature (30 °C) (Fig. 2A). The
pap-13 mutation, which is located between the
35 and
10
papBA hexamer RNA polymerase binding sites, significantly
reduced the affinity of Lrp for GATCprox (8). Thus, these
data support the hypothesis that RNA polymerase competes with Lrp for
binding at the papBA promoter.
Although our data showed that Lrp specifically repressed
papBA transcription initiated by RNAP-
70, the
repression mechanism has yet to be determined. Previous work showed
that Lrp repressed transcription from the D-amino acid
dehydrogenase (dad) promoter in vitro (32). Lrp
appeared to bind near the
35 hexamer region of the dad
promoter, similar to the binding of Lrp to the GATCprox
region of the papBA promoter. It is possible, therefore,
that Lrp could sterically interfere with binding of RNA polymerase to
these promoters. Lrp could repress transcription by alternative mechanisms such as interaction with transcriptional regulators or RNA
polymerase. For example, work by Rhee et al. (33) showed binding of Lrp to the leader-attenuator region of ilvGMEDA
226-bp downstream of the transcription start site is necessary for
repression. Repression of ilvGMEDA occurred at the same
concentration of Lrp (16 nM) as repression of
papBA transcription (Fig. 3 and Ref. 33).
A number of features of the methylation-dependent
regulatory system of pap are shared by other pili operons in
E. coli (34) and
Salmonella,4 which
play important roles in virulence. Recently, it was shown that DNA
methylation is essential for Salmonella virulence (35). The
pap system described here provides a useful paradigm for
understanding the mechanisms by which DNA methylation patterns are
established, altered by environmental stimuli (36, 37) and control gene expression.
 |
ACKNOWLEDGEMENTS |
We thank Dr. M. Krabbe for purified Lrp, Dr.
R. Matthews and Dr. W. Reznikoff for bacterial strains, and Drs.
B. A. Braaten and M. Krabbe for plasmids and critical reading of
this manuscript.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant AI23348 (to D.A.L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular,
Cellular, and Developmental Biology, Rm. 3129, Bioscience II Bldg.,
University of California, Santa Barbara, CA 93106. Tel.: 805-893-5597;
Fax: 805-893-7558; E-mail: low@lifesci.ucsb.edu.
2
M. Krabbe, unpublished data.
3
N. J. Weyand, unpublished data.
4
Nicholson, B. P., and Low, D. A. (2000)
Molecular Microbiology, in press.
 |
ABBREVIATIONS |
The abbreviations used are:
pap, pyelonephritis-associated pili;
Lrp, leucine-responsive protein;
Dam, DNA adenine methylase;
GATCprox, GATC site proximal to the
papBA promoter;
GATCdist, GATC site distal to
the papBA promoter;
PAGE, polyacrylamide gel
electrophoresis;
BSA, bovine serum albumin;
X-gal, 5-bromo-4-chloro-3-indolyl-
-D-galactoside;
PCR, polymerase chain reaction;
bp, base pair(s);
AMV, avian myeloblastosis
virus.
 |
REFERENCES |
| 1.
|
Hultgren, S. J.,
Abraham, S.,
Caparon, M.,
Falk, P.,
St. Geme, J. W. D.,
and Normark, S.
(1993)
Cell
73,
887-901[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Low, D.,
Robinson, E. N., Jr.,
McGee, Z. A.,
and Falkow, S.
(1987)
Mol. Microbiol.
1,
335-46[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Riggs, A. D.,
and Porter, T. N.
(1996)
in
Epigenetic Mechanisms of Gene Regulation
(Russo, V. E. A.
, Martienssen, R. A.
, and Riggs, A. D., eds)
, pp. 29-45, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 4.
|
Calvo, J. M.,
and Matthews, R. G.
(1994)
Microbiol. Rev.
58,
466-490[Abstract/Free Full Text]
|
| 5.
|
Newman, E. B.,
D'Ari, R.,
and Lin, R. T.
(1992)
Cell
68,
617-619[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Braaten, B. A.,
Nou, X.,
Kaltenbach, L. S.,
and Low, D. A.
(1994)
Cell
76,
577-588[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Blyn, L. B.,
Braaten, B. A.,
and Low, D. A.
(1990)
EMBO J.
9,
4045-4054[Medline]
[Order article via Infotrieve]
|
| 8.
|
Nou, X.,
Braaten, B.,
Kaltenbach, L.,
and Low, D. A.
(1995)
EMBO J.
14,
5785-5797[Medline]
[Order article via Infotrieve]
|
| 9.
|
van der Woude, M.,
Braaten, B.,
and Low, D.
(1996)
Trends Microbiol.
4,
5-9[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Nou, X.,
Skinner, B.,
Braaten, B.,
Blyn, L.,
Hirsch, D.,
and Low, D.
(1993)
Mol. Microbiol.
7,
545-553[Medline]
[Order article via Infotrieve]
|
| 11.
|
Kaltenbach, L. S.,
Braaten, B. A.,
and Low, D. A.
(1995)
J. Bacteriol.
177,
6449-6455[Abstract/Free Full Text]
|
| 12.
|
Braaten, B. A.,
Blyn, L. B.,
Skinner, B. S.,
and Low, D. A.
(1991)
J. Bacteriol.
173,
1789-1800[Abstract/Free Full Text]
|
| 13.
|
van der Woude, M. W.,
Kaltenbach, L. S.,
and Low, D. A.
(1995)
Mol. Microbiol.
17,
303-312[Medline]
[Order article via Infotrieve]
|
| 14.
|
van der Woude, M.,
Hale, W. B.,
and Low, D. A.
(1998)
J. Bacteriol.
180,
5913-5920[Abstract/Free Full Text]
|
| 15.
|
Símonían, M. H.
(1995)
in
Current Protocols in Protein Science
(Chanda, V. B., ed), Vol. 1
, pp. 3.1.1-3.1.7, Greene Publishing Associates/Wiley Interscience, New York
|
| 16.
|
Hulsmann, K. H.,
Quaas, R.,
Georgalis, Y.,
Saenger, W.,
and Hahn, U.
(1991)
Gene (Amst.)
98,
83-88[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Miller, J. H.
(1972)
Experiments in Molecular Genetics
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 18.
|
Kunkel, T. A.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
488-492[Abstract/Free Full Text]
|
| 19.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1989)
Current Protocols in Molecular Biology
, Greene Publishing Associates/Wiley Interscience, New York
|
| 20.
|
Lindsley, J. E.,
and Wang, J. C.
(1993)
J. Biol. Chem.
268,
8096-8104[Abstract/Free Full Text]
|
| 21.
|
Blyn, L. B.,
Braaten, B. A.,
White-Ziegler, C. A.,
Rolfson, D. H.,
and Low, D. A.
(1989)
EMBO J.
8,
613-620[Medline]
[Order article via Infotrieve]
|
| 22.
|
Jishage, M.,
Iwata, A.,
Ueda, S.,
and Ishihama, A.
(1996)
J. Bacteriol.
178,
5447-5451[Abstract/Free Full Text]
|
| 23.
|
Karls, R.,
Schulz, V.,
Jovanovich, S. B.,
Flynn, S.,
Pak, A.,
and Reznikoff, W. S.
(1989)
Nucleic Acids Res.
17,
3927-3949[Abstract/Free Full Text]
|
| 24.
|
Gross, C. A.,
Grossman, A. D.,
Liebke, H.,
Walter, W.,
and Burgess, R. R.
(1984)
J. Mol. Biol.
172,
283-300[Medline]
[Order article via Infotrieve]
|
| 25.
|
Hengge-Aronis, R.
(1996)
in
Escherichia coli and Salmonella: Cellular and Molecular Biology
(Neidhardt, F. C., ed), 2nd Ed., Vol. 1
, pp. 1497-1512, ASM Press, Washington, D. C.
|
| 26.
|
Beltrametti, F.,
Kresse, A. U.,
and Guzman, C. A.
(1999)
J. Bacteriol.
181,
3409-3418[Abstract/Free Full Text]
|
| 27.
|
Suh, S. J.,
Silo-Suh, L.,
Woods, D. E.,
Hassett, D. J.,
West, S. E.,
and Ohman, D. E.
(1999)
J. Bacteriol.
181,
3890-3897[Abstract/Free Full Text]
|
| 28.
|
Bearson, S. M.,
Benjamin, W. H., Jr.,
Swords, W. E.,
and Foster, J. W.
(1996)
J. Bacteriol.
178,
2572-2579[Abstract/Free Full Text]
|
| 29.
|
Marschall, C.,
Labrousse, V.,
Kreimer, M.,
Weichart, D.,
Kolb, A.,
and Hengge-Aronis, R.
(1998)
J. Mol. Biol.
276,
339-353[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Hu, J. C.,
and Gross, C. A.
(1983)
Mol. Gen. Genet.
191,
492-498[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Zhou, Y. N.,
Walter, W. A.,
and Gross, C. A.
(1992)
J. Bacteriol.
174,
5005-5012[Abstract/Free Full Text]
|
| 32.
|
Mathew, E.,
Zhi, J.,
and Freundlich, M.
(1996)
J. Bacteriol.
178,
7234-7240[Abstract/Free Full Text]
|
| 33.
|
Rhee, K. Y.,
Parekh, B. S.,
and Hatfield, G. W.
(1996)
J. Biol. Chem.
271,
26499-26507[Abstract/Free Full Text]
|
| 34.
|
van der Woude, M. W.,
Braaten, B. A.,
and Low, D. A.
(1992)
Mol. Microbiol.
6,
2429-2435[Medline]
[Order article via Infotrieve]
|
| 35.
|
Heithoff, D. M.,
Sinsheimer, R. L.,
Low, D. A.,
and Mahan, M. J.
(1999)
Science
284,
967-970[Abstract/Free Full Text]
|
| 36.
|
Hale, W. B.,
van der Woude, M. W.,
and Low, D. A.
(1994)
J. Bacteriol.
176,
3438-3441[Abstract/Free Full Text]
|
| 37.
|
Tavazoie, S.,
and Church, G. M.
(1998)
Nat. Biotechnol.
16,
566-571[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Harley, C. B.,
and Reynolds, R. P.
(1987)
Nucleic Acids Res.
15,
2343-2361[Abstract/Free Full Text]
|
| 39.
|
Hawley, D. K.,
and McClure, W. R.
(1983)
Nucleic Acids Res.
11,
2237-2255[Abstract/Free Full Text]
|
| 40.
|
Casadaban, M. J.
(1976)
J. Mol. Biol.
104,
541-555[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Mulvey, M. R.,
Sorby, P. A.,
Triggs-Raine, B. L.,
and Loewen, P. C.
(1988)
Gene (Amst.)
73,
337-345[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Parker, B.,
and Marinus, M. G.
(1988)
Gene (Amst.)
73,
531-535[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Yanisch-Perron, C.,
Vieira, J.,
and Messing, J.
(1985)
Gene (Amst.)
33,
103-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Ernsting, B. R.,
Denninger, J. W.,
Blumenthal, R. M.,
and Matthews, R. G.
(1993)
J. Bacteriol.
175,
7160-7169[Abstract/Free Full Text]
|
| 45.
|
Hanahan, D.
(1983)
J. Mol. Biol.
166,
557-580[Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Holden, M. Totsika, L. Dixon, K. Catherwood, and D. L. Gally
Regulation of P-Fimbrial Phase Variation Frequencies in Escherichia coli CFT073
Infect. Immun.,
July 1, 2007;
75(7):
3325 - 3334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Wagner and M. H. Mulks
Identification of the Actinobacillus pleuropneumoniae Leucine-Responsive Regulatory Protein and Its Involvement in the Regulation of In Vivo-Induced Genes
Infect. Immun.,
January 1, 2007;
75(1):
91 - 103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Casadesus and D. Low
Epigenetic Gene Regulation in the Bacterial World
Microbiol. Mol. Biol. Rev.,
September 1, 2006;
70(3):
830 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|